Navigation path

Pharmaceuticals - Union Register

  

Register of orphan medicinal products


GRANTED  

Product information

5-bromo-N-(prop-2-yn-1-yl)-2-(1H-1,2,4-triazol-1-yl)pyrimidine-4,6-diamine

EU orphan designation number: EU/3/14/1392   
Active ingredient: 5-bromo-N-(prop-2-yn-1-yl)-2-(1H-1,2,4-triazol-1-yl)pyrimidine-4,6-diamine
Indication: Treatment of Huntington’s disease
Sponsor: Palobiofarma S.L.
Avinguda Ernest Lluch 32, TCM2 0207, Tecnocampus, Mataro, 08302 Barcelona, España

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
18/12/2014 Orphan designation EMA/OD/169/14 (2014)10040 of 16/12/2014